Epilepsy is defined as a diverse set of neurological disorders characterized by seizures. These seizures occur due to abnormal electrical activity in the brain. Factors that may lead to epilepsy include, but are not limited to, brain trauma, gene mutations, strokes, brain cancer, and extensive drug and alcohol use. Seizures occur due to a large release of glutamate, which causes a spread of excitation throughout the brain, which propagates the electrical signal and can lead to neuronal death. Menstrual epilepsy, otherwise known as catamenial epilepsy, causes seizures in women due to the hormone levels in their bodies that are related to the menstrual cycle. Estrogen is an excitatory hormone, so when those levels rise during ovulation, seizures are more likely to occur. Progesterone is an inhibitory hormone, so when those levels drop during the start of the menstrual cycle, seizures are more likely to occur as well. About 50 million people have epilepsy, with 80% of that population located in developing countries. It is possible to control epilepsy with medicine, but many cases may require surgery in order to relieve symptoms.
Menstrual Epilepsy Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Menstrual Epilepsy below!
For more information on how to use Laverne, please read the How to Guide.
We have 909 products for the study of Menstrual Epilepsy that can be applied to Western Blot, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Chromatin Immunoprecipitation (ChIP), Immunohistochemistry from our catalog of antibodies and ELISA kits.